Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Epidemiology (Cambridge, Mass.)|December 25, 2002
Mortality of cystic fibrosis patients treated with tobramycin solution for inhalationKenneth J Rothman, Charles E Wentworth
The New England Journal of Medicine|September 8, 2010
Suicide-related events in patients treated with antiepileptic drugsAlejandro Arana, Charles E Wentworth, José L Ayuso-Mateos, et al.
Current Medical Research and Opinion|May 20, 2008
Dosage, titration, and gaps in treatment with extended release niacin in clinical practiceSachin J Kamal-Bahl, Thomas A Burke, Douglas J Watson, et al.
The Journal of Investigative Dermatology|November 11, 2006
Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitisFelix M Arellano, Charles E Wentworth, Alejandro Arana, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|July 21, 2011
Prescription patterns for asthma medications in children and adolescents with health care insurance in the United StatesFelix M Arellano, Alejandro Arana, Charles E Wentworth, et al.
Pharmacoepidemiology and Drug Safety|July 3, 2007
The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitusThomas A Burke, Miriam C Sturkenboom, Pamela A Ohman-Strickland, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2009
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United KingdomFelix M Arellano, Alejandro Arana, Charles E Wentworth, et al.
Journal of Hypertension|May 11, 2006
Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practiceThomas A Burke, Miriam C Sturkenboom, Shou-en Lu, et al.
Pharmacoepidemiology and Drug Safety|November 7, 2006
Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profileFélix M Arellano, Marianne Ulcickas Yood, Charles E Wentworth, et al.
Drug Safety|May 22, 2010
Infliximab paediatric Crohn's disease educational plan: a European, cross-sectional, multicentre evaluationAlejandro Arana, Sam Allen, Jörg Burkowitz, et al.
Pageof 2